Co-nanoencapsulated meloxicam and curcumin improves cognitive impairment induced by amyloid-beta through modulation of cyclooxygenase-2 in mice

Alzheimer’s disease (AD) is a progressive brain disorder and complex mechanisms are involved in the physiopathology of AD. However, there is data suggesting that inflammation plays a role in its development and progression. Indeed, some non-steroidal anti-inflammatory drugs, such as meloxicam, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutierrez, Maria Eduarda Ziani, Savall, Anne Suély Pinto, da Luz Abreu, Edina, Nakama, Kelly Ayumi, Dos Santos, Renata Bem, Guedes, Marina Costa Monteiro, Ávila, Daiana Silva, Luchese, Cristiane, Haas, Sandra Elisa, Quines, Caroline Brandão, Pinton, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067937/
https://www.ncbi.nlm.nih.gov/pubmed/33063743
http://dx.doi.org/10.4103/1673-5374.295339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067937/
https://www.ncbi.nlm.nih.gov/pubmed/33063743
http://dx.doi.org/10.4103/1673-5374.295339

Ejemplares similares